Max Healthcare shares rise 0.23 per cent in Wednesday’s trading session (16-10-2024)
The Relative Strength Index of the stock stood at 55.07 on Wednesday.
Pharma compliance issues (16-10-2024)
Thank you @harsh.beria93 and @sahil_vi for such a detailed post on compliance. Regarding the marketting point I understand its needed for biosimilars. But is it needed for other mainstream generics too ? As far as my understanding goes only avtive ingredient is prescribed by the prodcuts and price determines which generic pharmacist will give it to the patient
Shares of Tata Power fall as Nifty drops (16-10-2024)
On the technical charts, the 200-day moving average of the stock stood at Rs 416.32.
Share market update: Most active stocks of the day in terms of total traded value (16-10-2024)
The NSE Nifty index was trading 33.0 points down at 25024.35
Time to be cautious, next 3-4 months will separate boys from men: Dipan Mehta (16-10-2024)
Dipan Mehta recommends cautious stock investments due to high PE multiples and slow growth in key sectors. He believes the next three-four months will be critical. Stocks like HCL Tech and Infosys are near all-time highs, suggesting a potential market correction. Long-term investments and maintaining strategic cash reserves are advised.
Infosys Q2 preview: PAT may rise 11% YoY on deals ramp up; co may raise FY25 guidance (16-10-2024)
Infosys is projected to report an 11% YoY increase in PAT for Q2, driven by mega-deal ramp-ups and strong demand in financial services. Revenue is expected to grow around 5% YoY, with new financial guidance for FY25 potentially raised to 4-5% in constant currency terms.